News & Updates

Growing Scrutiny of Sketchy, Illusory Pharmacy Benefit Manager (PBM) Value Proposition Forces PCMA to Initiate Defensive DC PR Campaign

Placed on the defensive by a growing level of congressional scrutiny and unfavorable publicity surrounding lawsuits against the shadowy pharmacy benefit manager (PBM) industry, the Senior Care Pharmacy Coalition (SCPC) noted the Pharmaceutical Care Management Association (PCMA) is being forced to mount a defensive public relations effort to counter the growing perception that PBMs are anti-consumer, anti-taxpayer and anti-free market….Read More

Secretive Pharmacy Benefit Manager Pricing Schemes Face Growing, Bipartisan Capitol Hill Scrutiny

Morning Consult
When the notorious former Turing Pharmaceuticals CEO, Martin Shkreli, made a recent appearance on Capitol Hill to “invoke [his] fifth amendment rights” at a House Oversight and Government Reform Committee hearing on prescription drug pricing abuses, focus on his alleged misdeeds served a useful purpose: he put a face on the need for more competition and pricing transparency in America’s increasingly complex and tumultuous pharmaceutical marketplace…Read More

LTC exempted from newly-passed drug bill’s ‘lock-in’ provision

McKnight’s
A bill passed by the Senate on Thursday is earning praise from a leading long-term care pharmacy group for exempting nursing homes from its controversial “lock-in” provision that limits Medicare beneficiaries to using one pharmacy…Read More

SCPC Lauds CARA Final Senate Passage, Praises Key Toomey Provision Protecting Long-Term Care Patients’ Access to Essential Medications

Washington, DC — In praising today’s Senate passage of the Comprehensive Addiction and Recovery Act (CARA), the Senior Care Pharmacy Coalition (SCPC) thanked Senators Rob Portman (R-OH), Kelly Ayotte (R-NH), Mark Kirk (R-IL), Sheldon Whitehouse (D-RI), Amy Klobuchar (D-MN) and Christopher Coons (D-DE) and their colleagues in the U.S. Senate for helping place the nation’s opioid abuse epidemic front and center in the public spotlight…Read More

Independent LTC Pharmacy Advocacy Group Urges Stronger Effort on PDP Transparency in Response to CMS Draft 2017 Medicare Part D Call Letter

In response to the Centers for Medicare and Medicaid Service’s (CMS) draft 2017 Part D Call letter, the Senior Care Pharmacy Coalition (SCPC) urged still more rigorous efforts to ensure greater prescription drug plan (PDP) transparency in regard to Maximum Allowable Cost (MAC) pricing – despite a recent CMS initiative to do so…Read More

SCPC Comments on the CMS Draft 2017 Medicare Part D Call Letter

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to provide the following comments to the Center for Medicare and Medicaid Service’s (“CMS”) draft 2017 Part D Call Letter, dated February 19, 2016 (the “Call Letter”)….Read More

SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs’ Anti-Competitive, Non-Transparent Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients…Read More

House Members Want Greater Transparency on Drugs Reimbursement

Morning Consult
Sixteen House members are asking three pairs of committee leaders to consider a bill they say would improve transparency of the business partnerships between the government and pharmacy benefit managers…Read More

As Shkreli Puts Face on Drug Pricing Abuses, PBM Reimbursement Trends Analysis Prompts Long-Term Care Pharmacy Group to Call for Increased 2016 Congressional Investigation

Washington, DC — With former Turing Pharmaceuticals CEO Martin Shkreli significantly raising the public profile of prescription drug pricing abuses, the Senior Care Pharmacy Coalition (SCPC) is stepping up its criticism of anti-competitive pharmacy benefit manager (PBM) pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs’ pricing methodology leads to arbitrary and capricious reimbursement – warranting greater Congressional scrutiny and oversight in 2016…Read More

Senior Care Pharmacy Coalition (SCPC) Commends Oversight & Government Reform Committee Leaders for Examining Drug Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today commended House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) and Ranking Member Elijah Cummings (D-MD) for holding today’s hearing, “Developments in the Prescription Drug Market,” to examine exorbitant drug price increases and growing questions about abusive pharmacy benefit manager (PBM) pricing practices…Read More

Twitter   LinkedIn